Outcomes

Haematologic Technologies, Inc. was acquired by Edgewater Capital Partners

Outcomes

Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses

Outcomes

HistoGeneX combines with Caprion Biosciences via strategic investment from Arsenal Capital Partners

Outcomes

MolecularMD has been acquired by ICON Plc.

Outcomes

Transposagen Biopharmaceuticals, Inc. has been acquired by Lonza

Outcomes

PhenoPath has been acquired by Quest Diagnostics September 2018

Outcomes

OmniSeq Received a Strategic Investment from HITACHI April 12, 2018

Outcomes

MedLabs Diagnostics Recapitalized by Caymus Equity and PNC Mezzanine Capital April 3, 2018

Outcomes

Trevigen acquired by Bio-Techne September 5, 2017

Outcomes

OmniSeq Received a Strategic Investment from LabCorp August 21, 2017